SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,904.78 -73.14
(-0.15%)

Dow Jones

6,863.50 -36.75
(-0.53%)

Hang Seng

56,282.78 -1,774.46
(-3.06%)

Nikkei 225

10,473.49 -306.62
(-2.84%)

Forex

USD-INR

91.06 0.13
(0.14%)

EUR-INR

107.55 0.22
(0.20%)

GBP-INR

122.70 -0.27
(-0.22%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

31.52

7769.49

EPS(TTM)

Face Value()

Div & Yield %

5.44

0.47

Back

Hi-Klass Trading & Investment reports standalone net profit of Rs 1.23 crore in the December 2025 quarter

Feb 13,2026

Net profit of Hi-Klass Trading & Investment reported to Rs 1.23 crore in the quarter ended December 2025 as against net loss of Rs 0.08 crore during the previous quarter ended December 2024. Sales rose 6740.00% to Rs 3.42 crore in the quarter ended December 2025 as against Rs 0.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3.42	0.05	6740
OPM %	73.10	-560.00	-
PBDT	2.29	-0.08	LP
PBT	2.29	-0.08	LP
NP	1.23	-0.08	LP

80,238.85 -1,048.34 ( -1.29%)

48,904.78 -73.14 (-0.15%)

6,863.50 -36.75 (-0.53%)

56,282.78 -1,774.46 (-3.06%)

10,473.49 -306.62 (-2.84%)

91.06 0.13 (0.14%)

107.55 0.22 (0.20%)

122.70 -0.27 (-0.22%)

0.58 0.00 (0.12%)